DAE HWA Pharm대화제약
067080 · KOSDAQ · ₩067080 · 대화제약
₩9,170▼ ₩180 (1.93%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 35.3% | 33.4% | 35.6% | 32.1% | 34.9% | 37.3% |
| Operating margin | 3.7% | 2.2% | 4.5% | 1.4% | 4.4% | 2.8% |
| Net margin | 3.0% | 1.2% | 0.4% | −0.8% | 0.8% | 1.9% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +4.0% | −4.2% | +5.7% | +7.2% | +12.6% | — |
| Operating income growth | +74.9% | −52.9% | +241.8% | −66.4% | +78.1% | — |
| Net income growth | +168.1% | +211.2% | +146.3% | −202.8% | −49.7% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 5.7% | 2.3% | 0.7% | −1.5% | 1.4% | 2.8% |
| Return on assets | 2.2% | 1.1% | 0.4% | −0.2% | 0.6% | 1.1% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 157.0% | 166.4% | 169.6% | 183.3% | 143.7% | 112.6% |
| Net debt to equity | 116.0% | 120.2% | 127.5% | 136.8% | 105.9% | 78.7% |
| Current ratio | 55.7% | 51.3% | 52.3% | 51.0% | 61.5% | 74.5% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: DAE HWA Pharm / 대화제약 / 067080 / KRX:067080
Source: KRX statistical information